开发用于肝脏疾病的细胞膜相关脂质体
Dongxue Ge1, Ran An1, Lingling Xue1
1Division of Hepatobiliary and Transplantation Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, Clinical College of Nanjing University of Chinese Medicine, Nanjing 210008, China.
ACS nano
|October 15, 2024
概括
细胞膜相关的脂质体为肝脏疾病提供了有前途的药物输送. 需要进一步的研究来优化它们的使用,并克服治疗肝病理的临床挑战.
科学领域:
- 生物医学工程 生物医学工程
- 药物输送系统 药物输送系统
- 肝病学 肝病学是一种肝病学.
背景情况:
- 肝脏疾病正在增加,目前药理治疗的有效性有限.
- 脂质体增强药物输送到目标部位,提高治疗效果.
- 细胞膜相关的脂质体显示出潜力,但需要更深入地了解它们的结合机制.
研究的目的:
- 对肝病治疗的细胞膜相关脂质体进行审查.
- 总结它们的组成,类型,结构和药物输送策略.
- 讨论临床应用,挑战和未来前景.
主要方法:
- 关于细胞膜相关脂质体的综合文献综述.
- 分析它们的结构,组成和药物输送机制.
- 对治疗肝病的临床应用和挑战的评估.
主要成果:
- 细胞膜相关的脂质体为肝脏病理提供了增强的药物向.
- 使用这些脂质体,存在各种药物输送策略.
- 除了现有的临床挑战之外,还确定了重要的潜在益处.
结论:
- 细胞膜相关的脂质体显示出改善肝病治疗的前景.
- 进一步的研究对于优化它们的利用和解决临床障碍至关重要.
- 概述了未来的发展方向,以提高治疗结果.
相关概念视频
01:35Asymmetric Lipid Bilayer
Biological membranes show uneven distribution of different types of lipids in the inner and outer layers, resulting in transverse asymmetric membranes. The treatment of the erythrocyte membrane with the enzyme phospholipase confirmed the asymmetric nature of the lipid bilayer. The enzyme hydrolyzes lipids into fatty acids and hydrophilic groups. The phospholipase acts only on the outer layer of the membrane, while the inner layer remains intact. The phospholipase treatment resulted in 80%...
01:27Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...